DIAsource Overview
- Year Founded
-
1996

- Status
-
Acquired/Merged
- Employees
-
84

- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
3
- Investments
-
2
DIAsource General Information
Description
Manufacturer, developer and marketer of clinical diagnostics products designed to treat endocrinology and infectious diseases. The company's focus lies in offering a panel of accurate, reliable assays that allow the performant detection and measurement of various forms of Vitamin D metabolites, as well as developing new antibodies and assays to measure relevant biomarkers, enabling clients to detect and monitor endocrine disorders and infectious and auto-immune diseases.
Contact Information
Website
www.diasource-diagnostics.comCorporate Office
- Rue du Bosquet, 2
- 1348 Louvain-la-Neuve
- Belgium
Corporate Office
- Rue du Bosquet, 2
- 1348 Louvain-la-Neuve
- Belgium
DIAsource Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
DIAsource Comparisons
Industry
Financing
Details
DIAsource Competitors (29)
One of DIAsource’s 29 competitors is LEX Diagnostics, a Corporate Backed or Acquired company based in Melbourn, United Kingdom.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
LEX Diagnostics | Corporate Backed or Acquired | Melbourn, United Kingdom | ||||
ELITechGroup | Formerly PE-Backed | Puteaux, France | ||||
Hain Lifescience | Corporate Backed or Acquired | Nehren, Germany | ||||
BioGenex Laboratories | Corporation | Fremont, CA | ||||
Nanomix | Formerly VC-backed | San Leandro, CA |
DIAsource Patents
DIAsource Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20130084585-A1 | Immunoassay for chromogranin a, antibodies and kit | Active | 28-Apr-2010 | ||
US-9322828-B2 | Immunoassay for chromogranin a, antibodies and kit | Active | 28-Apr-2010 | ||
AU-2011247621-A1 | Immunoassay for chromogranin a, antibodies and kit | Active | 28-Apr-2010 | ||
AU-2011247621-B2 | Immunoassay for chromogranin a, antibodies and kit | Active | 28-Apr-2010 | ||
AU-2010236056-A1 | Process for the production of a hybridoma and antibody obtained therefrom, able to recognize more than one vitamin d metabolite | Active | 27-Oct-2009 | G01N33/82 |
DIAsource Signals
DIAsource Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
DIAsource Investments & Acquisitions (2)
DIAsource’s most recent deal was a Corporate Asset Purchase with Svar Life Science (Radioimmunoassay and Chromogranin A Neolisa). The deal was made on 30-Jul-2018.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Svar Life Science (Radioimmunoassay and Chromogranin A Neolisa) | 30-Jul-2018 | Corporate Asset Purchase | Buildings and Property | ||
Viro-Immun Diagnostics | 01-Sep-2017 | Merger/Acquisition | Diagnostic Equipment |
DIAsource FAQs
-
When was DIAsource founded?
DIAsource was founded in 1996.
-
Where is DIAsource headquartered?
DIAsource is headquartered in Louvain-la-Neuve, Belgium.
-
What is the size of DIAsource?
DIAsource has 84 total employees.
-
What industry is DIAsource in?
DIAsource’s primary industry is Diagnostic Equipment.
-
Is DIAsource a private or public company?
DIAsource is a Private company.
-
What is the current valuation of DIAsource?
The current valuation of DIAsource is
. -
What is DIAsource’s current revenue?
The current revenue for DIAsource is
. -
Who are DIAsource’s investors?
AnteoTech and Invitrogen have invested in DIAsource.
-
Who are DIAsource’s competitors?
LEX Diagnostics, ELITechGroup, Hain Lifescience, BioGenex Laboratories, and Nanomix are some of the 29 competitors of DIAsource.
-
When was DIAsource acquired?
DIAsource was acquired on 04-Sep-2017.
-
Who acquired DIAsource?
DIAsource was acquired by BioVendor Laboratorni Medicina.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »